Allergies News and Research

Latest Allergies News and Research

Sublingual immunotherapy can effectively treat peanut allergy

Peanuts are one of the most common triggers of severe food-induced allergic reactions, which can be fatal, and the prevalence of peanut allergy is increasing. However, there is currently no clinical treatment available for peanut allergy other than strict dietary elimination and, in cases of accidental ingestion, injections of epinephrine.

9 Jan 2013

Pollen exposure during late pregnancy increases risk of early asthma in child: Study

A woman's exposure to high pollen levels in late pregnancy increases the risk of early asthma in the child, according to a group of researchers at Sweden's Ume- University in a recent study.

8 Jan 2013

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA’s review to be completed in the first half of 2013.

7 Jan 2013

High vitamin D in pregnancy may increase food allergy risk in children

Study results published in Allergy suggest that supplementing pregnant women with vitamin D may increase their children’s risk for developing food allergy in infancy.

4 Jan 2013

Manipulating T cells with iPSC techniques could help develop effective immune therapies

The human body contains immune cells programmed to fight cancer and viral infections, but they often have short lifespans and are not numerous enough to overcome attacks by particularly aggressive malignancies or invasions.

4 Jan 2013

Nanoparticle researcher to deliver inaugural presentation at next ACS national meeting

A noted researcher in nanomedicine ― preventing, diagnosing and treating disease with particles so small that thousands fit across the width of a human hair ― will deliver the inaugural presentation in "The Kavli Foundation Emerging Leader in Chemistry Lecture" at the next National Meeting of the American Chemical Society (ACS).

4 Jan 2013

Researchers create killer T lymphocytes from iPS cells

Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan report today that they have succeeded for the first time in creating cancer-specific, immune system cells called killer T lymphocytes, from induced pluripotent stem cells (iPS cells).

4 Jan 2013

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

3 Jan 2013

Johns Hopkins scientists uncover itch-specific nerve cells in skin

3 Jan 2013

Children diagnosed with food allergies experience bullying

Nearly a third of children diagnosed with food allergies who participated in a recent study are bullied, according to researchers at the Icahn School of Medicine at Mount Sinai. Almost eight percent of children in the U.S. are allergic to foods such as peanuts, tree-nuts, milk, eggs, and shellfish.

25 Dec 2012

Atopy patch tests predict oral tolerance in children with milk allergy

Results from an Italian study show that atopy patch tests could predict oral tolerance in children with gastrointestinal symptoms related to non-IgE-mediated cow’s milk allergy.

22 Dec 2012

CHPA praises signing into law of anti-methamphetamine bill

The Consumer Healthcare Products Association (CHPA) today applauded Ohio Governor John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Representative Terry Johnson (R-Portsmouth) and Representative Danny Bupb (R-West Union). With the new law, Ohio now becomes the 25th state to adopt real-time, stop-sale technology known as the National Precursor Log Exchange (NPLEx).

21 Dec 2012

Voluntary moratorium on H5N1 avian flu research likely to end soon

Following the conclusion of a two-day meeting at the National Institutes of Health (NIH) this week -- meant "to gather feedback from flu researchers, others in the science community, and the public on its draft framework for funding H5N1 gain-of-function studies and to continue an international dialogue on issues related to benefits and risks of the research" -- "experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon," CIDRAP News reports.

21 Dec 2012

Tips to prevent food allergies during Christmas

Chestnuts roasting on an open fire, candles filling the air with the smell of cinnamon and beloved decorations making their yearly appearance really do help make the season bright. But for kids with allergies these holiday delights can make the atmosphere miserable and even deadly.

19 Dec 2012

HAL Allergy completes enrollment in SUBLIVAC FIX Phleum pratense Phase II trial

HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II trial with SUBLIVAC FIX Phleum pratense.

19 Dec 2012

Children in asthma hotspots more likely to experience exercise-induced wheeze

Asthmatic children in New York City neighborhoods with high rates of asthma make many more visits to the emergency room (ER) than those who live in other parts of the city. While socioeconomic factors such as lack of adequate preventive care are part of the equation (high-asthma neighborhoods tend to be lower income), new research points to a possible biological basis for the disparity.

18 Dec 2012

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

University of Maryland School of Medicine researchers have launched groundbreaking research into the spread of potentially deadly drug-resistant malaria in the developing Southeast Asian nation of Myanmar, also known as Burma.

17 Dec 2012

God will control my asthma

Research shows that patients’ belief in God influences how likely they are to be adherent to asthma medication.

14 Dec 2012

Fatal imbalance between global disease burden and drug development

Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.

13 Dec 2012